Search Results

You are looking at 1 - 1 of 1 items for

  • Author: Suli Wang x
Clear All Modify Search
Open access

Suli Wang, Chun Qiao, Yu Zhu, Wenyi Shen, Guangsheng He and Jianyong Li

Abstract

Blast crisis (BC) is the major remaining challenge in the management of chronic myeloid leukemia (CML). The prognosis of the BC patient who carries ABL kinase mutation is very poor. One patient, with lymphoid CML-BC third time, was detected with T315A/F359I/M244V compound mutation by direct sequencing after treatment with tyrosine kinase inhibitions three years. The patient was treated with decitabine, dexamethasone, in combination with nilotinib and dasatinib. Then this patient received a complete hematologic response and cytogenetic response after two cycles of treatment.